Listing 1 - 8 of 8 |
Sort by
|
Choose an application
Outside back cover : "Despite decades of attention on building a global HIV research and programming agenda, HIV in older populations has generally been neglected until recently. This new book focuses on HIV and aging in the context of ageism with regard to prevention, treatment guidelines, funding, and the engagement of communities and health and social service organizations. The lack of perceived HIV risk in late adulthood among older people themselves, as well on the part of providers and society in general, has led to a lack of investment in education, testing, and programmatic responses. Ageism perpetuates the invisibility of older adults and, in turn, renders current medical and social service systems unprepared to respond to patients’ needs. While ageism may lead to some advantages – discounts for services, for example – it is the negative aspects that must be addressed when determining the appropriate community-level response to the epidemic."
Aging - physiology --- HIV Infections - complications --- Aging --- HIV Infections
Choose an application
HIV Infections --- Nutrition Disorders --- Trace Elements --- AIDS (Disease) --- Malnutrition --- Trace elements in nutrition --- complications --- HIV Infections - complications
Choose an application
Quatrième de couverture : "Biologie appliquée de l'infection à VIH et de ses comorbidités en Afrique Biologie appliquée de l'infection à VIH et de ses comorbidités en Afrique est né du travail mené depuis plus de dix ans par les auteurs au sein du Diplôme universitaire de virologie biologique de Dakar, et de leurs efforts pour forger un corpus pédagogique cohérent. Cet ouvrage s'articule autour des trois grands axes développés dans cette formation : un vade-mecum faisant le point sur les connaissances actuelles ; 167 QCM inédits, destinés à renforcer le savoir analytique ; une série d'observations clinicobiologiques, menant le lecteur vers une démarche synthétique intégrant toute la diversité du savoir transmis. Il propose ainsi des solutions techniques, pratiques et pragmatiques applicables au monitoring biologique de l'infection au VIH et de ses comorbidités, et met également en avant les questions non résolues, qui font encore l'objet de débats dans la communauté scientifique et médicale."
HIV Infections --- Comorbidity --- complications --- Infections à VIH --- Complications --- Africa. --- complications. --- Complications. --- HIV Infections - complications --- Comorbidity - Africa --- Africa
Choose an application
Révélé au monde il y a vingt ans, le SIDA est aujourd'hui reconnu comme une maladie sexuellement transmissible qui peut atteindre n'importe quel individu qui n'a pas respecté des principes élémentaires de protection. La femme est particulièrement sensible et exposée aux infections transmises lors des rapports sexuels, du fait de ses particularités anatomiques et des conditions socio-économiques et culturelles susceptibles de limiter son information et ses possibilités de prévention. Rédigé par les plus grands spécialistes francophones de la question, Le SIDA au féminin dresse un bilan de l'épidémie et propose une synthèse des travaux sur les femmes face au VIH, aujourd'hui, dans le monde. Fruit d'une collaboration pluridisciplinaire, il aborde des points très divers : la particularité et l'évolution de la maladie chez la femme, la transmission sexuelle du VIH et les possibilités de prévention et de contraception, les questions soulevées lors d'une grossesse, le diagnostic et la prise en charge thérapeutique. Cet ouvrage s'adresse aux gynécologues-obstétriciens, aux pédiatres et à tous les médecins, sages-femmes, travailleurs sociaux et psychologues qui sont, ou seront un jour ou l'autre, en contact avec des femmes séropositives.
HIV Infections --- Pregnancy Complications, Infectious --- Genital Diseases, Female --- complications --- epidemiology --- Aids --- Vrouwen --- Sida --- Femmes --- HIV Infections - complications --- HIV Infections - epidemiology
Choose an application
Choose an application
Liver disease has been identified as a leading cause of death in HIV-infected patients since the introduction of highly active antiretroviral therapy (HAART) in 1996. The HIV treatment community has been caught largely unaware of this emerging dilemma. Many HIV care providers are ill-equipped to understand and interpret liver injury patterns, or to provide comprehensive care and management for viral coinfections which they are not familiar with. HIV and Liver Disease provides a comprehensive update of the field covering the epidemiology, pathogenesis, management and treatment of liver disease in patients with HIV infection. The volume will help HIV care providers understand and interpret liver injury patterns, and/or provide comprehensive care and management for viral coinfections. Gastroenterologists and hepatologists will gain an understanding of complex drug regimens that are used to treat HIV and which may impact HCV and HBV treatment. Written by expert clinicians and researchers across multiple disciplines, HIV and Liver Disease will be of great value to gastroenterologists, hepatologists, infectious disease practitioners, as well as other health care providers who provide care or participate in research in the field of HIV.
HIV infections -- Complications. --- HIV infections. --- Liver -- Diseases. --- Liver --- HIV infections --- Virus Diseases --- Sexually Transmitted Diseases, Viral --- Drug Therapy, Combination --- Digestive System Diseases --- Hepatitis --- Immunologic Deficiency Syndromes --- Lentivirus Infections --- Drug Therapy --- Diseases --- Retroviridae Infections --- Immune System Diseases --- Sexually Transmitted Diseases --- Therapeutics --- RNA Virus Infections --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Hepatitis, Viral, Human --- HIV Infections --- Liver Diseases --- Antiretroviral Therapy, Highly Active --- Medicine --- Health & Biological Sciences --- Gastroenterology --- Complications --- Diseases. --- HIV (Viruses) infections --- HTLV-III infections --- HTLV-III-LAV infections --- Human T-lymphotropic virus III infections --- Medicine. --- Internal medicine. --- Gastroenterology. --- Hepatology. --- Medicine & Public Health. --- Internal Medicine. --- Lentivirus infections --- Sexually transmitted diseases --- Clinical medicine. --- Medicine, Internal --- Medicine, Clinical --- Internal medicine --- Digestive organs --- Gastroenterology .
Choose an application
The introduction of highly active antiretroviral therapy (HAART) has significantly improved the clinical outcome of HIV disease with increased survival rates. However, the introduction of HAART has generated a contrast in the cardiac manifestations of AIDS. In developed countries, we observed an approximate 30% reduction in the prevalence of HIV-associated cardiomyopathy, possibly related to a reduction of opportunistic infections and myocarditis. In developing countries, however, where the availability of HAART is limited and the pathogenic impact of nutritional factors is significant, we observed an approximate 32% increase in the prevalence of HIV-associated cardiomyopathy and a related high mortality rate from congestive heart failure. Additionally, some HAART regimens in developed countries, especially those including protease inhibitors, may cause an iatrogenic metabolic syndrome (HIV-lipodystrophy syndrome) that is associated with an increased risk of cardiovascular disease. At the same time, the relapse of some opportunistic infections, with possible myocardial involvement, in HIV-infected patients receiving HAART, in the context of the recently described immune reconstitution inflammatory syndrome, yielded an intriguing and complex profile of this dual aspect of cardiology in AIDS in the HAART era. In this new edition of Cardiovascular Disease in AIDS, new insights coming from basic and clinical research in the field of HIV-associated cardiovascular disease and antiretroviral therapy are reported, along with the clinical guidelines for a careful stratification of the cardiovascular risk and cardiovascular monitoring of HIV-infected patients receiving HAART. The authors offer a wide overview of the topic for specialists in cardiology and infectious diseases involved in the clinical management of HIV-infected patients.
Acquired Immunodeficiency Syndrome -- complications. --- AIDS (Disease) -- Complications. --- Antiretroviral agents. --- Antiretroviral Therapy, Highly Active -- adverse effects. --- Cardiovascular Diseases -- etiology. --- Cardiovascular system -- Diseases -- Etiology. --- HIV Infections -- complications. --- Diseases --- Drug Therapy, Combination --- Immunologic Deficiency Syndromes --- Slow Virus Diseases --- Sexually Transmitted Diseases, Viral --- Lentivirus Infections --- Virus Diseases --- Retroviridae Infections --- Immune System Diseases --- Sexually Transmitted Diseases --- Drug Therapy --- Therapeutics --- RNA Virus Infections --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Acquired Immunodeficiency Syndrome --- HIV Infections --- Antiretroviral Therapy, Highly Active --- Cardiovascular Diseases --- Medicine --- Health & Biological Sciences --- Clinical Immunology --- AIDS (Disease) --- Cardiovascular system --- Complications. --- Etiology. --- Circulatory system --- Vascular system --- Anti-retroviral agents --- Antiretroviral drugs --- Antiretrovirals --- Medicine. --- Internal medicine. --- Angiology. --- Cardiology. --- Infectious diseases. --- Medicine & Public Health. --- Infectious Diseases. --- Internal Medicine. --- Antiviral agents --- Blood --- Circulation --- Angiography. --- Emerging infectious diseases. --- Medicine, Internal --- Emerging infections --- New infectious diseases --- Re-emerging infectious diseases --- Reemerging infectious diseases --- Communicable diseases --- Blood-vessels --- Diagnosis, Radioscopic --- Radiography, Medical --- Heart --- Internal medicine --- Radiography
Choose an application
Chemokines and their receptors are being recognized as an integral component of the nervous system implicated in fundamental aspects of development and homeostasis, such as neurotransmission, proliferation, differentiation, and neuronal-glial communication. Thus, their involvement in HIV neuropathology goes far beyond the co-receptors role and entails complex interactions of the chemokine system with different cell types and other regulators of neuronal function. The major goal of this volume is to review these topics in order to highlight alterations of chemokine physiology that may contribute to neuroAIDS and other neuropathologies. This book will be of interest to neuroscientists, neurologists, virologists, pharmacologists, and students in these fields. About the Editor: Olimpia Meucci, MD, PhD is a Professor of Pharmacology and Physiology & Microbiology and Immunology at Drexel University College of Medicine in Philadelphia, PA. Since her seminal discovery about the regulation of neuronal signaling by chemokines, her research has primarily focused on the physio-pathological roles of this important class of neuroimmune modulators in the central nervous system and their involvement in neuroAIDS. These studies have significantly contributed to current understanding of the cellular and molecular mechanisms of HIV-related neuropathology including the interaction of the chemokine system with drug of abuse, namely opiates, which continues to be a major area of investigation in the Meucci lab.
AIDS (Disease) -- Complications -- Treatment. --- Chemokines -- Receptors. --- Chemokines. --- HIV infections -- Complications -- Treatment. --- Chemokines --- AIDS (Disease) --- HIV infections --- Nervous system --- Antigens, CD --- Cytokines --- Diseases --- Immunologic Deficiency Syndromes --- Inflammation Mediators --- Receptors, Cytokine --- Sexually Transmitted Diseases, Viral --- Biological Science Disciplines --- Slow Virus Diseases --- Receptors, G-Protein-Coupled --- Lentivirus Infections --- Chemotactic Factors --- Physiology --- Acquired Immunodeficiency Syndrome --- Nervous System Diseases --- HIV Infections --- Receptors, Chemokine --- Immune System Diseases --- Intercellular Signaling Peptides and Proteins --- Antigens, Differentiation --- Sexually Transmitted Diseases --- Biological Factors --- Natural Science Disciplines --- Retroviridae Infections --- Receptors, Cell Surface --- Receptors, Immunologic --- Virus Diseases --- Proteins --- Chemicals and Drugs --- Disciplines and Occupations --- Antigens, Surface --- RNA Virus Infections --- Peptides --- Membrane Proteins --- Biological Markers --- Amino Acids, Peptides, and Proteins --- Antigens --- Medicine --- Biology --- Microbiology & Immunology --- Neurology --- Health & Biological Sciences --- Receptors --- Complications --- Treatment --- Chemotherapy --- Receptors. --- Treatment. --- Chemotherapy. --- HIV (Viruses) infections --- HTLV-III infections --- HTLV-III-LAV infections --- Human T-lymphotropic virus III infections --- Acquired immune deficiency syndrome --- Acquired immunodeficiency syndrome --- Acquired immunological deficiency syndrome --- Chemotactic cytokines --- Inflammatory peptides --- Intercrines --- Medicine. --- Neurosciences. --- Pharmacology. --- Virology. --- Infectious diseases. --- Biomedicine. --- Pharmacology/Toxicology. --- Infectious Diseases. --- Organs (Anatomy) --- Neurosciences --- Lentivirus infections --- Sexually transmitted diseases --- Immunological deficiency syndromes --- Virus-induced immunosuppression --- Inflammation --- Mediators --- Medical virology. --- Toxicology. --- Emerging infectious diseases. --- Emerging infections --- New infectious diseases --- Re-emerging infectious diseases --- Reemerging infectious diseases --- Communicable diseases --- Chemicals --- Pharmacology --- Poisoning --- Poisons --- Medical microbiology --- Virology --- Virus diseases --- Neural sciences --- Neurological sciences --- Neuroscience --- Medical sciences --- Toxicology --- Drug effects --- Medical pharmacology --- Drugs --- Pharmacy --- Microbiology --- Physiological effect
Listing 1 - 8 of 8 |
Sort by
|